Andrew Von-Eschenbach Insider Profile
4 Followers
Andrew Von-Eschenbach, Director at Bausch + Lomb Corporation, holds 63.73K shares in Bausch + Lomb Corporation (Ticker: BLCO), holds ― shares in TriSalus Life Sciences (Ticker: TLSI), holds 336.07K shares in Celularity (Ticker: CELU). Most recently, Andrew Von-Eschenbach Sold ― shares of Bausch + Lomb Corporation on Aug 10, 2026 for an estimated value of $306.71K.
Andrew Von-Eschenbach Bausch + Lomb Corporation (BLCO)Director
Bausch + Lomb Corporation (BLCO)
Director
Ranked #29,631 out of 109,106 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+12.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Andrew Von-Eschenbach's holdings
Insider Roles
Roles that Andrew Von-Eschenbach holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 11, 2020 - Mar 11, 2021
Return:+86.30%
The most profitable trade made by Andrew Von-Eschenbach
Andrew Von-Eschenbach's Trading History
Bausch + Lomb Corporation
Aug 10, 2026
Director
Informative Sell
306.71K
$1.07M
TriSalus Life Sciences
―
Director
―
―
Lineage Therap
Aug 14, 2013
Director
Informative Buy
11.07K
$3.09K
Bausch Health Companies
Aug 09, 2021
Director
Informative Buy
36.32K
$219.90K
Celularity
Jun 16, 2023
Director
Uninformative Buy
―
$463.77K
Radius Health
Aug 15, 2022
―
Uninformative Sell
55.00K
$0.00
Asterias Biotherapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Andrew Von-Eschenbach's performance on stock
You May Also Like
Andrew Von-Eschenbach insider profile FAQ
What is the percentage of profitable transactions made by Andrew Von-Eschenbach?
The percentage of profitable transactions made by Andrew Von-Eschenbach is 50%.
What is the average return per transaction made by Andrew Von-Eschenbach?
The average return per transaction made by Andrew Von-Eschenbach is 12.90%.
What stocks does Andrew Von-Eschenbach hold?
Andrew Von-Eschenbach holds: BLCO, TLSI, LCTX, BHC, CELU, ~RDUS, AST stocks.
What was Andrew Von-Eschenbach’s latest transaction?
Andrew Von-Eschenbach latest transaction was an Informative Sell of $306.71K.
What was Andrew Von-Eschenbach's most profitable transaction?
Andrew Von-Eschenbach’s most profitable transaction was an Informative Buy of BHC stock on March 11, 2020. The return on the trade was 86.30%.
What is Andrew Von-Eschenbach's role in Bausch + Lomb Corporation?
Andrew Von-Eschenbach's role in Bausch + Lomb Corporation is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.